3 terminated, 1 completed. 2 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Clorazepate Dipotassium: new trials by email Literature Review of Clorazepate Dipotassium trials Research Report on Clorazepate Dipotassium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room Clorazepate Dipotassium, Placebo, Ketoprofen - Migraine, Migraine Without Aura | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 323 | 2021-07-08 | 2025-09-08 |
| Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas Methotrexate, Interferon Alfa-2b - Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides | Phase 4 | Terminated | Polish Lymphoma Research Group | 100 | 2014-06-01 | 2022-01-13 |
| Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression C-ECT, PHARMACOTHERAPY - Depression | Phase 4 | Terminated | Hospital Universitari de Bellvitge | 104 | 2009-07-01 | 2015-08-31 |
| Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions Clorazepate Dipotassium 15mg Tablets - Healthy | Not applicable | Completed | Ranbaxy Laboratories Limited | 32 | 2003-08-01 | 2008-10-20 |
Depression (1) · Headache (1) · Lymphoma, T-Cell, Cutaneous (1) · Migraine Disorders (1) · Migraine with Aura (1) · Migraine without Aura (1) · Mycosis Fungoides (1)
Assistance Publique - Hôpitaux de Paris (1) · Hospital Universitari de Bellvitge (1) · Polish Lymphoma Research Group (1) · Ranbaxy Laboratories Limited (1)
France (1) · Poland (1) · Spain (1) · United States (1)
Ewa Chmielowska, MD, PhD (1) · Mikel Urretavizcaya Sarachaga, MD, PhD (1)